- Home
- UEC vs MIRM Comparison
UEC vs MIRM Comparison
Compare UEC & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEC
- MIRM
- Stock Information
- Founded
- UEC 2003
- MIRM 2018
- Country
- UEC United States
- MIRM United States
- Employees
- UEC N/A
- MIRM N/A
- Industry
- UEC Other Metals and Minerals
- MIRM Biotechnology: Pharmaceutical Preparations
- Sector
- UEC Basic Materials
- MIRM Health Care
- Exchange
- UEC Nasdaq
- MIRM Nasdaq
- Market Cap
- UEC 3.0B
- MIRM 2.5B
- IPO Year
- UEC N/A
- MIRM 2019
- Fundamental
- Price
- UEC $5.68
- MIRM $52.45
- Analyst Decision
- UEC Strong Buy
- MIRM Strong Buy
- Analyst Count
- UEC 2
- MIRM 11
- Target Price
- UEC $10.63
- MIRM $57.00
- AVG Volume (30 Days)
- UEC 6.7M
- MIRM 504.4K
- Earning Date
- UEC 03-10-2025
- MIRM 02-26-2025
- Dividend Yield
- UEC N/A
- MIRM N/A
- EPS Growth
- UEC N/A
- MIRM N/A
- EPS
- UEC N/A
- MIRM N/A
- Revenue
- UEC $17,203,000.00
- MIRM $307,028,000.00
- Revenue This Year
- UEC $60,962.50
- MIRM $83.04
- Revenue Next Year
- UEC $34.61
- MIRM $27.22
- P/E Ratio
- UEC N/A
- MIRM N/A
- Revenue Growth
- UEC N/A
- MIRM 112.14
- 52 Week Low
- UEC $4.06
- MIRM $23.14
- 52 Week High
- UEC $8.93
- MIRM $54.23
- Technical
- Relative Strength Index (RSI)
- UEC 28.88
- MIRM 64.07
- Support Level
- UEC $5.84
- MIRM $51.02
- Resistance Level
- UEC $7.20
- MIRM $53.76
- Average True Range (ATR)
- UEC 0.34
- MIRM 2.04
- MACD
- UEC -0.12
- MIRM 0.03
- Stochastic Oscillator
- UEC 3.79
- MIRM 73.31
About UEC Uranium Energy Corp.
Uranium Energy Corp is engaged in uranium mining and related activities. The company is working towards fueling the demand for carbon-free nuclear energy, a key solution to climate change, and energy source for the low-carbon future. The company is advancing its next generation of low-cost, environmentally friendly, in-situ recovery (ISR) mining uranium projects. The company has two extraction-ready ISR hub and spoke platforms in South Texas and Wyoming. UEC also has seven U.S. ISR uranium projects with all of their permits in place, with additional diversified holdings of uranium assets across the U.S., Canada and Paraguay.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter "IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.